Dr. Scheibler joined Apellis in April 2018 as Executive Vice President for Research and Translational Medicine. In this role, he will be responsible to create and manage all preclinical research projects and advance them into clinical development to establish proof of concept. Dr. Scheibler is an R&D professional with in depth experiences in drug development. He most recently was head of R&D at Acucela, a Seattle based startup and had a 13-year career in research and development, business development and clinical development at Novartis. He holds a PhD from the University of Lausanne, Switzerland and a post doctoral training at Harvard Medical School.